EyeArt is an AI-enabled medical device from Eyenuk, Inc, listed by FDA (510(k), K200667) with a decision date of 2020-08-03. Review panel: Ophthalmic.
| FDA submission number | K200667 |
|---|---|
| Pathway | 510(k) |
| Company | Eyenuk, Inc |
| Review panel (specialty) | Ophthalmic |
| FDA decision date | 2020-08-03 |
| Decision | Substantially Equivalent |
| Product code | PIB |
| Classification | Diabetic Retinopathy Detection Device |
| Device class | 2 |
| Regulation number | 886.1100 |
| Review time (calendar days) | 143 |
| Applicant country | US |
Official FDA database record · FDA AI-enabled device list
All Ophthalmic AI devices · Full device index
Data from FDA's AI-enabled device list and openFDA. Informational only; verify against the FDA record.